Label (Lbl721622466)
Pirfenidone Tablet, Coated
Product Images NDC 72162-2466
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 72162-2466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Pirfenidone Figure1)
This data provides information on the percentage of patients who experienced worsening, no change, or improvement in Forced Vital Capacity (%FVC) after treatment with Pirfenidone or Placebo. The results show the absolute change in %FVC from baseline to week 52 for patients under both treatments. This can be helpful in analyzing the effectiveness of Pirfenidone compared to Placebo in maintaining or improving lung function over time.*
Figure 2 (Pirfenidone Figure2)
The text provides data on the mean change in forced vital capacity (FVC) in milliliters over several weeks for patients taking Pijrfenidone (n=278) compared to those taking Placebo (n=277). The graph shows the difference in FVC levels between the two groups over a 52-week period.*
Figure 3 (Pirfenidone Figure3)
This text provides information on the percentage of patients alive over time comparing Pirfenidone with a placebo. The analysis shows the Hazard Ratio (HR) of 0.75 (95% CI: 0.51 to 1.11) for Pirfenidone compared to Placebo based on the data from 623 and 624 patients, respectively. The graph illustrates the survival rates over 120 weeks for both treatment groups.*
Pirfenidone-pi-table1 (Pirfenidone Pi Table 1)
This text provides a dosing schedule for Pirfenidone Tablets 267mg in morning, afternoon, and evening doses for different weeks. The schedule increases the daily pill intake gradually from 3 pills in the first week to 9 pills from day 15 onwards. It outlines the distribution of pills for each meal (Breakfast, Lunch, Dinner) over the specified time periods.*
Pirfenidone-pi-table-2 (Pirfenidone Pi Table 2)
This text provides a dosing schedule for Pirfenidone Tablets 801 mg starting from day 15 onward. The schedule involves taking 1 tablet in the morning, 1 tablet in the afternoon, and 1 tablet in the evening, totaling 3 pills per day.*
Pirfenidone (Pirfenidone Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
